Lepore M R, Yoselevitz M, Sternbergh W C, Money S R
Sections on Vascular Surgery (MRL, WCS, SRM) and Interventional Radiology (MY), Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA.
Ochsner J. 2000 Jul;2(3):145-52.
The recent and continuing developments in radiotherapy, gene therapy, and the technologies of imaging, materials, and devices, as well as the techniques for their implementation, have expanded the options available for the treatment of peripheral vascular disease. Though long-term data are still lacking, percutaneous transluminal angioplasty (PTA) has developed into a treatment modality in its own right and continues to be an adjuvant treatment to traditional surgical revascularization. Numerous stents and grafts are currently available for the treatment of arterial lesions and aneurysms, while the testing of many more continues. In addition to these new devices, developments in gene therapy and brachytherapy have brought several new minimally invasive options to the treatment of peripheral vascular disease.
放射治疗、基因治疗以及成像、材料和设备技术及其实施技术的最新及持续发展,拓宽了外周血管疾病的治疗选择。尽管仍缺乏长期数据,但经皮腔内血管成形术(PTA)已发展成为一种独立的治疗方式,并且仍然是传统外科血管重建的辅助治疗方法。目前有多种支架和移植物可用于治疗动脉病变和动脉瘤,同时还有更多产品正在进行测试。除了这些新设备,基因治疗和近距离放射治疗的发展为外周血管疾病的治疗带来了几种新的微创选择。